[1]
Wazir, N. and Rehman, S.U. 2022. Evaluating Impact of Empagliflozin on Lipid Profile of Patients of Type 2 Diabetes Mellitus. Journal of Gandhara Medical and Dental Science. 9, 3 (Jul. 2022), 20–24. DOI:https://doi.org/10.37762/jgmds.9-3.174.